- 上一篇：中国创业板上市公司股利分配研究
- 下一篇：光伏企业财务预警分析与危机防范研究
摘要自二十一世纪以来，全球经济快速发展，市场竞争不断加剧，企业为了在激烈竞争的市场中求生存、求发展，采取了各种办法来武装自己，形成企业的核心竞争力。企业进行研发活动，进行知识和技术的创新，能够从根本上增强企业的优势，因此研发活动对企业的生存和发展至关重要。但近年来我国研发投入占GDP的比重仍然很低，且大部分企业并没有健全的研发机构，反映出我国企业对研发活动缺乏重视和系统的组织与管理。我国企业整体竞争力弱，自主创新能力不足，在很大程度上与企业研发投入不足和业绩低下有关系。所以，有必要研究研发投入与企业业绩之间的关系，为企业制定研发投入决策提供理论和实证研究的依据。同时，对于上市公司的成长以及全国经济的稳定发展都具有十分重要的意义。制药业板块作为我国上市公司中重要组成部分，对其经营业绩的研究也就有着重要的意义。64860
本文首先从制药业的研发费用与业绩评价的关系进行研究分析，根据前人研究成果提出假设，紧接着选取相关变量，建立模型。选取医药制造业上市公司的数据作为研究样本，利用一定方法进行分析，确定研发费用与各个评价指标之间的关系，进而得出制药业研发费用与企业业绩之间的关系。
关键词 研发费用 业绩评价 制药业
毕业论文 外 文 摘 要
Title Pharmaceutical industry R&D costs and performance
evaluation of empirical research
Abstract
When the 21st century comes, the global economy rapidly develop, In order to survive in the highly competitive market, enterprises have to increase market competition and take a variety of ways to arm themselves, forming the core competitiveness of enterprises. Taking research and development activities, creating knowledge and technology innovation can fundamentally enhance a company’s advantage, thus, it is crucial for a enterprise to take an activities of the R&D. But in recent years, China's R&D investment share the low GDP, and most companies do not have a regular R&D institutions, reflecting the Chinese enterprises lack of attention and the organization and management of R&D activities. Therefore, it is necessary to study the relationship between R&D investment and corporate performance, to provide the basis of theoretical and empirical research for enterprises to develop R&D investment decisions. How to evaluate the operating performance of listed companies fairly and objectively, as well as its operating performance measures, it has great significance for the healthy growth of listed companies and the stable development of the national economy.
Keywords R&D expenses Performance Evaluation Pharmaceutical industry
目次
1 引言 1
2 相关概念概述 3
2.1我国制药业现状分析 3
2.2 研发费用概述 4
2.3 经营绩效概述 5
2.4 研发费用与企业业绩的关系 6
3 实证研究设计 8
3.1 提出假设 8
3.1.1 理论依据 8
3.1.2 具体假设 10
3.2 变量的选取 11
3.2.1 公司绩效变量 11
3.2.2 研发投入变量 11
3.2.3 其他控制变量